Home > Publications > CBCRP Annual Reports — 1997 > Summary of Awards by Institution

Summary of Awards by Institution

Chart

Beckman Research Institute of the City of Hope	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Fujita-Yamaguchi, Yoko Receptor Antibody-Enhanced Chemotherapy for Breast Cancer	2.0	$200,000	$152,000	$352,000

Burnham Institute	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Frisch, Steven Reprogramming Breast Cancer Epithelial Cells	1.0	$50,000	$47,500	$97,500
LeCalvez, Herve The Role of Meltrin-a in Breast Cancer-Associated Bone Loss	2.0	$70,000	$5,600	$75,600
Lin, Emme Integrin Activation in the Metastasis of Breast Cancer	2.0	$70,000	$5,600	$75,600
Malkhoysan, Sergei Molecular Karyotyping of Breast Cancer by DNA Fingerprinting	2.0	$149,000	$141,550	$290,550
Pasqualini, Renata Superfibronectin: A Novel Anti-Breast Cancer Agent	2.0	$200,000	$190,001	$390,001
Perucho, Manuel Identifying Novel Breast Cancer Tumor Suppressor Genes	1.0	$50,000	$47,500	$97,500
Rampino, Nicholas Genetic Repair of Oxidative Damage: Effect of Estrogen	3.0	$311,996	$294,021	$606,017
Smith, Jeffrey Targeting T Cells to Breast Cancer	2.0	$200,000	$190,000	$390,000
Zapata, Juan TRAF-regulated Signal Transduction in Breast Cancer	2.0	$70,000	$5,600	$75,600
Zhang, Xiao-kun Breast Cancer Chemoprevention by Retinoids	3.0	$498,000	$469,300	$967,300
		$1,668,996	$1,396,672	$3,065,668

CHG Foundation	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Howard, Nicole Increasing Annual Recall in State Early Detection Program	1.0	$78,879	$7,843	$86,722

California Pacific Medical Center Research Institute	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Debs, Robert Gene Therapy for Breast Cancer	2.0	$199,996	$93,387	$293,383
Desprez, Pierre-Yves Novel Breast Cancer Epithelial Cell Metalloproteinase	2.0	$149,842	$44,153	$193,995
Levine, Ellen The Efficacy of Retreat for Low-Income Women with Breast Cancer	1.0	$72,699	$20,719	$93,418
		$422,537	$158,259	$580,796

Cancer Research Fund of Contra Costa	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Yang, Jason Hormonal Control of Normal Breast Tissue	3.0	$210,790	$255,055	$465,845

Charles R. Drew University of Medicine & Science	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Sklansky, Jack Computer-Aided Diagnosis in Digital Mammography	2.0	$150,000	$64,200	$214,200

Charlotte Maxwell Complementary Clinic	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Levenberg, Shoshana The Efficacy of a Retreat for Low-Income Women with Breast Cancer	1.0	$72,699	$20,719	$93,418

City of Hope National Medical Center	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Balon, Thomas Nitric Oxide's Role in Breast Cancer Metabolism and Growth	1.0	$50,000	$24,000	$74,000

La Jolla Institute for Allergy and Immunology	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Huflejt, Margaret Galectin-4 As a New Marker for Breast Cancer	2.0	$110,000	$86,900	$196,900

Lawrence Berkeley National Laboratory	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Campisi, Judith Does Cell Aging Cause Breast Cancer?	2.0	$149,998	$90,214	$240,212
Galande, Sanjeev Breast Carcinoma Associated MAR-binding Proteins p90 and p70	2.0	$69,999	$0	$69,999
Guerra-Vladusic, Fabiana Characterization of Heregulin Targeted Genes	2.0	$70,000	$0	$70,000
Lupu, Ruth The Role of a Novel Estrogen Receptor in Breast Cancer	2.0	$150,000	$90,996	$240,996
Pujuguet, Philippe ECM-Regulated Transcription in Breast Cancer	2.0	$70,000	$0	$70,000
Shyamala, G. Fate Mapping of Progesterone Receptor Positive Breast Cells	2.0	$149,968	$95,249	$245,217
		$659,965	$276,459	$936,424

Lyon Martin Women's Health Services	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Roberts, Stephanie Breast Cancer Risk Factors: Lesbian & Heterosexual Women	1.0	$20,862	$3,129	$23,991

Northern California Cancer Center	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Harness, Jay The Breast Care Center: Innovative Care for the Underserved	2.0	$199,917	$71,171	$271,088
Pangene Corporation Zarling, David Recombination and Mutation in Breast Cancer	2.0	$150,000	$110,988	$260,988
		$349,917	$182,159	$532,076

Public Health Institute	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Reynolds, Peggy Breast Cancer Incidence in California Flight Attendants	1.0	$49,830	$7,092	$56,922

SRI International	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Tanabe, Masato Novel Enzyme Inhibitors for Estrogen-Dependent Breast Cancer	2.0	$195,638	$183,409	$379,047
Zaveri, Nurulain Blocking Stromelysin-3 to Inhibit Breast Cancer Metastasis	2.0	$199,983	$159,509	$359,492
		$395,621	$342,918	$738,539

Salk Institute for Biological Studies	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Chapman, Mark Molecular Analysis of BRCA1 Function	2.0	$70,000	$5,600	$75,600

Scripps Research Institute	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Bokoch, Gary The Role of PAK2 in Breast Cancer Cell Death	3.0	$305,071	$224,078	$529,149
Gottesfeld, Joel Inhibitors of the Breast Cancer Her-2/neu Gene	2.0	$197,038	$145,758	$342,796
Jackson, Janis Harline Analysis of Rac Mutations in Breast Cancer	1.0	$49,950	$37,463	$87,413
Maruyama, Ichiro Growth Factor Receptor Activation in Breast Cancer	2.0	$154,816	$112,475	$267,291
Ochs, Robert Autoantibodies in Breast Cancer	1.0	$74,360	$55,770	$130,130
Rose, David Integrin Receptor Activation in Breast Cancer	2.0	$70,000	$5,600	$75,600
Sato, Kevin Disruption of Cyclin E/Cell Cycle In Breast Cancer Cells	2.0	$70,000	$5,600	$75,600
		$921,235	$586,744	$1,507,979

Sidney Kimmel Cancer Center	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Mercola, Daniel Enhancing Breast Cancer Sensitivity to Chemotherapy	2.0	$200,000	$186,800	$386,800
Reynolds, Wanda Hormonal Control of HER2neu and BRCA1 in Breast Cancer	2.0	$148,380	$138,586	$286,966
		$348,380	$325,386	$673,766

Sierra Nevada Memorial Hospital Cancer Center	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Kreshka, Mary A Community-Based Workbook for Helping Rural Cancer Patients	1.0	$37,500	$10,361	$47,861

Stanford University	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Koopman, Cheryl A Community-based Workbook for Helping Rural Cancer Patients	1.0	$37,750	$21,904	$59,654
Lu, Yuefeng Modulation of Drug Resistance by Protein Kinase C Inhibitors	2.0	$70,000	$5,600	$75,600
Wolf, Dieter Control of DNA Replication in Breast Cancer	2.0	$70,000	$5,600	$75,600
		$177,750	$33,104	$210,854

University of California, Berkeley	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Buehring, Gertrude Bovine Leukemia Virus and Human breast Cancer Risk	2.0	$150,000	$0	$150,000
Firestone, Gary Dietary Indole Inhibition of Breast Cancer	2.0	$150,000	$0	$150,000
Kingsbury, Linda Bovine Leukemia Virus and Mammary Cell Infection	2.0	$69,981	$0	$69,981
Nandi, Satyabrata Identification of Pregnancy-associated Breast Cancer Genes	1.0	$50,000	$0	$50,000
		$419,981	$0	$419,981

University of California, Davis	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Enan, Essam Organochlorine Insecticides and Breast Cancer	3.0	$322,374	$0	$322,374
Nalcioglu, Orhan MRI Detection of Breast Cancer Blood Vessels	2.0	$149,935	$0	$149,935
Tanjasiri, Sora Breast Cancer Knowledge/Attitudes:So. Cal. Pacific Islanders	2.0	$70,000	$0	$70,000
Theisen, Heidi Regulation of Wnt: Clues for breast cancer pathognesis	2.0	$70,000	$0	$70,000
		$612,309	$0	$612,309

University of California, Los Angeles	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Kagawa-Singer, Marjorie Breast Screening Program in the Hmong American Community	1.0	$75,000	$0	$75,000
Morrison, Sherie Antibody Fusion Proteins for the Therapy of Breast Cancer	2.0	$193,224	$0	$193,224
Pardridge, William New imaging Modality for Early Detection of Breast Cancer	2.0	$150,000	$0	$150,000
		$418,224	$0	$418,224

University of California, San Francisco	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Dibble, Suzanne Breast Cancer Risk Factors: Lesbian & Heterosexual Women	1.0	$31,943	$0	$31,943
Shuman, Marc Inhibition of Angiogenesis in Breast Cancer	1.0	$75,000	$0	$75,000
		$106,943	$0	$106,943

University of California, Santa Cruz	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Konopelski, Joseph Novel drugs to inhibit breast cancer metastasis	2.0	$197,564	$0	$197,564

University of Southern California	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Coetzee, Gerhard Estrogen Formation and Breast Cancer Risk	2.0	$150,000	$96,781	$246,781
Enger, Shelley Hormone Receptors and Breast Cancer Survival	2.0	$69,519	$5,562	$75,081
Formenti, Silvia Biochemical Correlates for Clinical Response to Paclitaxel	1.0	$74,608	$48,464	$123,072
Ingles, Sue Ann Vitamin D Receptor Gene and Breast Cancer Risk	2.0	$148,531	$93,272	$241,803
Koprowski, Carol Physical Activity, Diet and Menarche in a Multiethnic Cohort	2.0	$70,000	$5,600	$75,600
Mack, Thomas Mammogram Density, Cancer, Inheritance & Acquired Risk:Twins	3.0	$771,749	$501,533	$1,273,282
Weber, Jeffrey Peptide-pulsed Dendritic Cell Therapy for Breast Cancer	2.0	$208,989	$104,581	$313,570
Wu, Anna Gene-Diet/Tobacco Interactions in Breast Cancer in Asians	3.0	$455,234	$295,848	$751,082
Zhou, Qing Breast Cancer Gene Therapy Using a Metastasis Inhibitor	2.0	$70,000	$5,600	$75,600
		$2,018,630	$1,157,241	$3,175,871